CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Finance Lease, Interest Payment on Liability
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Finance Lease, Interest Payment on Liability of $1.45 million for the 12-month period ending 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FinanceLeaseInterestPaymentOnLiability · last filed 2026-02-18
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for the quarter ending 2021-12-25 was $308.00K, a 3.75% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for the quarter ending 2021-09-25 was $318.00K, a 1.55% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for the quarter ending 2021-06-26 was $328.00K, a 1.55% increase year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for the quarter ending 2021-03-27 was $328.00K, a 3.53% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for fiscal 2025 was $1.45M, a 5.23% decline from fiscal 2024.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for fiscal 2024 was $1.53M, a 3.59% increase from fiscal 2023.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for fiscal 2023 was $1.48M, a 2.36% increase from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. finance lease, interest payment on liability for fiscal 2022 was $1.44M, a 12.48% increase from fiscal 2021.
| Period end | Finance Lease, Interest Payment on Liability 3 month | Finance Lease, Interest Payment on Liability 3 month as first filed | Finance Lease, Interest Payment on Liability 6 month | Finance Lease, Interest Payment on Liability 6 month as first filed | Finance Lease, Interest Payment on Liability 9 month | Finance Lease, Interest Payment on Liability 12 month |
|---|---|---|---|---|---|---|
| 2025-12-27 | $1.45M 10-K · filed 2026-02-18 | |||||
| 2024-12-28 | $1.53M 10-K · filed 2026-02-18 | |||||
| 2023-12-30 | $1.48M 10-K · filed 2026-02-18 | |||||
| 2022-12-31 | $1.44M 10-K · filed 2025-02-19 | |||||
| 2021-12-25 | $308.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | $626.00K derived: sum of 2 quarters · filed 2024-02-14 | $954.00K derived: sum of 3 quarters · filed 2024-02-14 | $1.28M 10-K · filed 2024-02-14 | ||
| 2021-09-25 | $318.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $646.00K derived: sum of 2 quarters · filed 2021-11-03 | $974.00K 10-Q · filed 2021-11-03 | $1.29M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-06-26 | $328.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $656.00K 10-Q · filed 2021-08-04 | $976.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.30M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2021-03-27 | $328.00K 10-Q · filed 2021-05-04 | $648.00K derived: sum of 2 quarters · filed 2023-02-22 | $971.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.29M derived: sum of 4 quarters · filed 2023-02-22 | ||
| 2020-12-26 | $320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $643.00K derived: sum of 2 quarters · filed 2023-02-22 | $966.00K derived: sum of 3 quarters · filed 2023-02-22 | $1.31M 10-K · filed 2023-02-22 | ||
| 2020-09-26 | $323.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $646.00K derived: sum of 2 quarters · filed 2021-11-03 | $986.00K 10-Q · filed 2021-11-03 | $1.33M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-06-27 | $323.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $663.00K 10-Q · filed 2021-08-04 | $1.01M derived: sum of 3 quarters · filed 2022-02-16 | $1.35M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2020-03-28 | $340.00K 10-Q · filed 2021-05-04 | $688.00K derived: sum of 2 quarters · filed 2022-02-16 | $1.03M derived: sum of 3 quarters · filed 2022-02-16 | $1.39M derived: sum of 4 quarters · filed 2022-02-16 | ||
| 2019-12-28 | $348.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $691.00K derived: sum of 2 quarters · filed 2022-02-16 | $1.05M derived: sum of 3 quarters · filed 2022-02-16 | $1.41M 10-K · filed 2022-02-16 | ||
| 2019-09-28 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $706.00K derived: sum of 2 quarters · filed 2020-10-29 | $1.06M 10-Q · filed 2020-10-29 | |||
| 2019-06-29 | $363.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $715.00K 10-Q · filed 2020-08-05 | $715.00M 10-Q · filed 2019-07-31 | |||
| 2019-03-30 | $352.00K 10-Q · filed 2020-05-07 | $352.00M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |